Fasting Comparative Bioavailability of Two Tablet Formulations of Levodopa /Benserazide in Healthy Volunteers (PHOE10903)

This study has been completed.

Sponsor:

Collaborator:

Laboratorios Phoenix S.A.I.C.y F.

Information provided by:

University of Buenos Aires

ClinicalTrials.gov Identifier:

NCT01327261

First received: March 28, 2011

Last updated: August 3, 2011

Last verified: March 2011

History of Changes

No Study Results Posted on ClinicalTrials.gov for this Study

About Study Results Reporting on ClinicalTrials.gov

Study Status:	This study has been completed.
Study Completion Date:	December 2009
Primary Completion Date:	October 2009 (Final data collection date for primary outcome measure)

No publications provided by University of Buenos Aires

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):

Keller GA, Czerniuk P, Bertuola R, Spatz JG, Assefi AR, Di Girolamo G. Comparative bioavailability of 2 tablet formulations of levodopa/benserazide in healthy, fasting volunteers: a single-dose, randomized-sequence, open-label crossover study. Clin Ther. 2011 Apr;33(4):500-10.

To Top